Bijoy Hans Limited has received official approval from the Registrar of Companies (ROC), Central Registration Centre (CRC), and Ministry of Corporate Affairs (MCA) for its proposed name change to 'Arvaya Healthcare Limited.' This development follows the company's recent board decisions regarding corporate rebranding strategy.

ROC Approval Details

The Ministry of Corporate Affairs issued the name availability approval on March 12, 2026, through the Central Registration Centre in Manesar. The approval was processed under Section 4(5) of the Companies Act, 2013, following the company's application dated March 11, 2026.

Board Meeting and Strategic Decisions

The company's Board of Directors had convened on March 11, 2026, where they approved the name change proposal subject to regulatory approvals. This decision came after the board had previously withdrawn an earlier approved name change to 'Arvaya Healthtech Limited' due to revised strategic business decisions.

Regulatory Compliance and Next Steps

The ROC approval comes with specific conditions and time constraints. The name availability is valid for 60 days from the approval date and does not grant any inherent rights or privileges. The approval is subject to compliance with Sections 4(2), 4(3), and other applicable provisions of the Companies Act, 2013.

Bijoy Hans Limited will now proceed to obtain shareholder approval for the name change, with a separate intimation to be filed with stock exchanges upon completion. The company has communicated this development to BSE Limited and The Calcutta Stock Exchange Limited in compliance with Regulation 30 of SEBI Listing Regulations.

Corporate Information

Bijoy Hans Limited, incorporated with CIN L86100AS1985PLC002323, trades on BSE with scrip code 524723 and on The Calcutta Stock Exchange with scrip code 012097. The regulatory communication was signed by Company Secretary and Compliance Officer Guinea Agrawal (Membership No: A60654), ensuring proper disclosure to all stakeholders and regulatory authorities.

Bijoy Hans Limited has informed stock exchanges about a crucial board meeting scheduled for March 17, 2026, where directors will consider multiple strategic corporate decisions. The company has issued a formal notice to the Bombay Stock Exchange and The Calcutta Stock Exchange Limited under Regulation 29 of SEBI Listing Regulations.

Key Agenda Items

The board meeting will address several significant corporate restructuring matters that require regulatory and shareholder approvals:

Executive Leadership Changes

The board will deliberate on important leadership and remuneration matters affecting key executives:

• Remuneration Revision: Managing Director Kaushal Shah's compensation package will be reviewed and revised, subject to necessary approvals
• CFO Compensation: Chief Financial Officer Abhiram Ranganath's remuneration will also undergo revision
• Leadership Transition: Salil Shetty's designation will change from Non-Executive Director to Executive Director and Chief Executive Officer, pending required approvals

Corporate Governance Matters

The meeting agenda encompasses several governance and structural changes:

Regulatory Compliance

The notice, dated March 12, 2026, was signed by Guinea Agrawal, Company Secretary and Compliance Officer, from Pune. The communication ensures compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, providing advance notice to stakeholders about the significant corporate decisions under consideration.

The comprehensive agenda reflects the company's strategic focus on organizational restructuring, financial flexibility enhancement, and governance framework modernization. All proposed changes requiring member approval will be subject to appropriate shareholder consent processes.